![]() |
Trials |
A multicentre open randomized phase II study of the efficacy and safety of azacitidine alone or in combination with lenalidomide in high-risk myeloid disease (high-risk MDS and AML) with a karyotype including del(5q)Cancer type: Leukemia Phase: II Principal Investigator: Noergaard Jan M. Country: DK Keywords: Denmark, Aarhus Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/show/NCT01556477 |